Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Frontiers in Neurology
|
January 30, 2025
Effect of acupuncture on the gait disturbance and hemodynamic changes in the prefrontal cortex: a study protocol for a randomized controlled trial
Zhenmei Hong, Shuijing Zhang, Shuqing Zhang, et al.
Biomed Research International
|
April 21, 2023
Three-Dimensional Gait Analysis and sEMG Measures for Robotic-Assisted Gait Training in Subacute Stroke: A Randomized Controlled Trial
Huihuang Zhang, Xiang Li, Yichen Gong, et al.
Nature Communications
|
July 12, 2025
Bioinspired Sulfo oxygen bridges optimize interfacial water structure for enhanced hydrogen oxidation and evolution reactions
Chengdong Yang, Yun Gao, Zhengyu Xing, et al.
Neurorehabilitation
|
June 21, 2024
Activation changes in patients with post-stroke cognitive impairment receiving intermittent theta burst stimulation: A functional near-infrared spectroscopy study
Hong Yu, Beisi Zheng, Youmei Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Michael B Atkins, F Stephen Hodi, John A Thompson, et al.
The Lancet. Oncology
|
July 22, 2017
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial
Georgina V Long, Victoria Atkinson, Jonathan S Cebon, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Frontiers in Neurology
|
January 30, 2025
Effect of acupuncture on the gait disturbance and hemodynamic changes in the prefrontal cortex: a study protocol for a randomized controlled trial
Zhenmei Hong, Shuijing Zhang, Shuqing Zhang, et al.
Biomed Research International
|
April 21, 2023
Three-Dimensional Gait Analysis and sEMG Measures for Robotic-Assisted Gait Training in Subacute Stroke: A Randomized Controlled Trial
Huihuang Zhang, Xiang Li, Yichen Gong, et al.
Nature Communications
|
July 12, 2025
Bioinspired Sulfo oxygen bridges optimize interfacial water structure for enhanced hydrogen oxidation and evolution reactions
Chengdong Yang, Yun Gao, Zhengyu Xing, et al.
Neurorehabilitation
|
June 21, 2024
Activation changes in patients with post-stroke cognitive impairment receiving intermittent theta burst stimulation: A functional near-infrared spectroscopy study
Hong Yu, Beisi Zheng, Youmei Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Michael B Atkins, F Stephen Hodi, John A Thompson, et al.
The Lancet. Oncology
|
July 22, 2017
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial
Georgina V Long, Victoria Atkinson, Jonathan S Cebon, et al.
Page
of 2